comparemela.com

Page 2 - Immunology Allergies Asthma News Today : Breaking News, Live Updates & Top Stories | Vimarsana

UT extension receives grants for COVID-19 and other vaccine education

 E-Mail KNOXVILLE, Tenn. According to the Tennessee Department of Health, 35.3 percent of Tennesseans have received at least one dose of a COVID-19 vaccine. However, of Tennessee s 95 counties, 18 have vaccination rates of 20 percent or below. Two grants from the U.S. Department of Agriculture with funds awarded to University of Tennessee Extension hope to change that. UT Extension has offices in all 95 counties across Tennessee, so we are in a unique position to be able to assist with vaccine education and combat misinformation, states Lisa Washburn, UT Extension community health specialist and principal investigator for the grant. In many communities across the state and the nation, Extension may be perceived as a more credible or highly trusted source than other government entities that do not have a local presence, adds Washburn. Our goal is to utilize local partnerships with the community to increase vaccine rates and continue to eliminate COVID-19 infection and transm

An atlas of the brain s choroid plexus across the lifespan

Choroid plexus tissue, anchored in each of the brain s ventricles and bathed in cerebrospinal fluid, is a small but influential player in the brain. It s now been spatially inventoried with single-cell RNA sequencing, cataloguing its cell types and gene expression patterns in each ventricle during early development, adulthood, and old age.

Hospitalized individuals with active cancer more likely to die from COVID-19

New research indicates that patients hospitalized with active cancer were more likely to die from COVID-19 than those with a history of cancer or those without any cancer diagnosis. The findings published by Wiley early online in CANCER, a peer-reviewed journal of the American Cancer Society, also indicate those with active blood cancers have the greatest risk of death due to COVID-19.

Pfizer-BioNTech vaccine recipients have lower antibody levels targeting the Delta variant

Levels of antibodies in the blood of vaccinated people that are able to recognise and fight the new SARS-CoV-2 Delta variant first discovered in India (B.1.617.2) are on average lower than those against previously circulating variants in the UK, according to new laboratory data from the Francis Crick Institute and the National Institute for Health Research (NIHR) UCLH Biomedical Research Centre, published as a Research letter in The Lancet.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.